GPPS 2019 Committee

Dr Adele Hosseini is a Director of Clinical Affairs, APAC, she is a trusted, collaborative and highly experienced Clinical Affairs professional supplemented with a PhD in Pharmacy and a 17-year foundation in leadership, global clinical research and university lecturing, providing exposure across pharmaceuticals, clinical research organization, medical devices, academia and governance. Her research specialties include: • Broad clinical research experience in Asia-Pacific region • Driving business by taking technical into commercial • Expertise in operational analysis and strategy development • Expertise and experience across Asia Pacific region • Leading projects to success on time and in budget • Experience in clinical development and management of pharmaceutical products • Strong background in clinical operations in the APAC region

Dr Zahra Darya Eftekhari has Accomplished pharmacy leader with 15 years of experience in varied pharmacy settings. A track record of strategic thinking, focused implementation of initiatives that have improved patient care, safety and increased efficiency of health care delivery. Excels at developing relationships with Key Opinion Leaders, senior management and internal stakeholders to achieve issue resolution and alignment with organizational objectives. Able to critically review, interpret and leverage scientific literature, applicable laws, regulations, and current standards of practice to influence key decisions and policies affecting hospital medication management and patient care delivery. Proven success in establishment and accreditation of acute hospital & long-term care, develop policies, procedures, formulary, P&T committee, Antibiotic Stewardship and Medication Safety (MERP), successful implementation of hospital wide technology (pharmacy software, EMAR and automation) and cost containment strategies. Doctor of pharmacy from University of the Pacific

Dr Rachel Cameron earliest experiences in working amid complexity started in the 90s while growing the hepatitis C virus! Motivated by these challenges and her desire to become a leader, she subsequently attained a PhD in Medicine from the University of Sydney and Stanford. Very quickly she found herself leading a lab of three scientists within the Global pharmaceutical company CSL Ltd. This was followed by a role at Biota Holdings Limited where she set up a new anti-viral testing facility, led the scientists and lectured at Monash University on the nuances of drug design. Recognizing that Dr Rachel Cameron have an uncommon talent for helping people to make sense of things she embarked on a series of subsequent senior recruitment, medical and commercial appointments within Tanner Menzies Executive Recruitment, Bristol Myers Squibb Australia Pty Ltd, Pro-Scribe Pty Ltd and Amgen Australia Pty Ltd. Dr Rachel Cameron work has been within Pharmaceuticals, Biotechnology, and Nutraceutical businesses and she have taught at University of Sydney, University of Melbourne, Monash University and the Southern School of Natural Therapies. Dr Rachel Cameron competencies exist within Leadership Development, Project Management, Medical Affairs, Training, Executive Coaching, Life Coaching, Recruitment, HR, Health Promotion, Writing and Editing, Public Speaking, Sales and Client Management.

Dr. Sami El Khatib, Assistant Dean of the School of Arts & Sciences at Lebanese International University (LIU), Holder of a PhD in Cell Biology, a Master Degree in Bioengineering & Biomaterials, University Diploma in Animal Experimentation from France, and a BS in Medical Laboratory from LU. His research work was focused on the non-invasive techniques of diagnosis and treatment of Bladder Cancer, published in international peer reviewed journals. He is the Head of the Organizing Committees of many academic and community services events organized by LIU. Dr. El Khatib is a member of the Middle East Molecular Biology Society, a member of MEMBS International Advisory Committee, and the World Academy of Science and Technology (WASET).

Abeer M. Rababa’h, PhD, associate professor of pharmacology at Jordan University of Science and Technology (JUST), Irbid, Jordan. Dr Rababa’h Joined the faculty as an assistant professor in Jordan University of Science and Technology, School of Pharmacy, Department of Clinical Pharmacy in September 2013. She was appointed as Assistant Dean of Experiential Education, JUST, Irbid, Jordan in 2017. She received the Association of Arab Universities (AARU-2017) Best Researcher Award in the field of Medical Sciences. The Association of Arab Universities is a non-governmental organization that has an independent legal character. Its membership includes 260 Arab Universities at the present time. Dr.Rababa’h research work focuses on the potential role of oxidative stress in the development of cardiovascular diseases. She has more than twenty publications and several funded grants. Dr.Rababa’h has been a member of ASPET, AHA and MEMBS. She is a member of the Divisions of Cardiovascular Pharmacology and Molecular Pharmacology.

After completion of his postdoctoral training at University of Texas MD Anderson Cancer Center, Dr Gautam Sethi joined Department of Pharmacology, Yong Loo Lin School of Medicine, the National University of Singapore in 2008 as an Assistant Professor and was promoted to Associate Professor in 2015. The focus of his research over the past few years has been to elucidate the mechanism (s) of activation of oncogenic transcription factors such as NF-kB/STAT3 by carcinogens and inflammatory agents and the identification of novel inhibitors of these proteins for prevention of and therapy for cancer. The findings of his research work have so far resulted in more than two hundred and fifty scientific publications in high impact factor peer reviewed journals (with h index = 76) and several international awards. He currently serves as an Academic Editor for PLOS, editorial board member of Cancer Letters, Scientific Reports, Pharmacological Research, World Journal of Pharmacology, BMC Cancer, Frontiers in Pharmacology, Frontiers in Oncology, International Journal of Biological Sciences, Journal of Functional Foods, Journal of Natural Products in Cancer Prevention and Therapy, and ad-hoc reviewer for several other prestigious international journals.

Dr. Mohsen l. Afouna is a Professor and Chairman, Dept. of Pharmaceutics & Pharm. Tech., College of Pharmacy-Al-Azhar Uni. Nasr City, Cairo, Egypt Highly motivated scientist (teacher, researcher) with expertise in development of oral, topical, transdermal and sterile (ocular & parenteral) drug delivery systems. In addition to extensive experienced in development, physico- (chemical/-mechanical) and in vivo characterization of noano-pharmaceutical drug delivery systems. Outstanding teaching & research experience in pharmaceutical sciences, development and management of scientific research projects combined with fluency in English and Arabic. High experience regarding chirality, physical & clinical pharmacy, biopharmaceutics & pharmacokinetics. He has excellent written and oral communication skills with supervisory and teaching experience. He is also Author of several recent articles, review articles and chapter in textbooks. Driven pharmaceutical scientist, love to work in a dynamic teaching, research and development environment.

Dr Ali Zarrabi is an Associate Professor and the Head of Department of Biotechnology at the University of Isfahan. His current research interests include Nanobiotechnology, Nanomedicine, Drug Delivery Systems, Nanotheranostics, Nanomaterials, SPIONs and Surface Modifications. Dr. Zarrabi has been a member of American Chemical Society (ACS), British Society for Nanomedicine, European Society for Nanomedicine, American Association for the Advancement of Science (AAAS), Nanotechnology Strategic Committee of University of Isfahan, Biotechnology Strategic Committee of University of Isfahan, Talented Students Committee of University of Isfahan, Iranian Genetic Society and Iran Nanotechnology Initiative. He received his B.S. of Chemical Engineering from Isfahan University of Technology, Iran, in 2004, and the M.S. and PhD degrees from Sharif University of Technology, Tehran, in Chemical Engineering (2007) and Nanobiotechnology (2011), respectively.

Dr. Alaa Bagalagel, Pharm.D., CDE, is the dean of Faculty of Pharmacy, University of Tabuk. Dr. Bagalagel was the director of pharmaceutical training unit at Faculty of Pharmacy, King Abdulaziz University. Dr. Bagalagel earned his Doctor of Pharmacy degree from King Abdulaziz University after which time he completed Pharmacy Practice Residency and Ambulatory Care Specialty Residency training at The University of Arizona. Dr. Bagalagel completed a Postdoctoral Fellowship at The University of Arizona. His area of research includes: clinical safety and efficacy of bio-similar, diabetes care, and drug reactions. Dr. Bagalagel is Certified Diabetes Educator. He provides a service as Ambulatory care consultant at King Abdulaziz University Hospital. He is an active member of the bio-similar working group at The University of Arizona Health Outcomes and PharmacoEconomic Center. Also, he is a board member of Saudi Pharmaceutical Society Western Region club.

Dr. Yazan Al-Rashdan is currently working as a Dean of College of Pharmacy, at Amman Arab University. He has been working in academia for more than eight years now, both in and outside of Jordan. During this time, He have taught and delivered courses (theoretical & practical) within a handful of faculties of pharmacy. Further, He has supervised PharmD students in their final clerkship clinical year. In collaboration with national and international researchers, He performed experimental work related to the medical/pharmaceutical field that has been published in reputable journals.